摘要 |
Described is a method of predicting a risk of a diabetes type 1 patient to suffer from one or more complications selected from cardiovascular complications, terminal renal failure, and death, the method involving a) determining the amount of a cardiac troponin, preferably troponin T, in a sample of a diabetes type 1 patient; and optionally b) determining the amount of a natriuretic peptide, preferably NT-proBNP, in a sample of a diabetes type 1 patient; and c) comparing the amount of the cardiac troponin and optionally the natriuretic peptide determined in steps a) and b) to reference amounts, and establishing a prediction. Also described are devices and kits for carrying out the aforementioned methods.
|